US OTC Birth Control NDA Could Debut ‘Additional Conditions for Nonprescription Use’ Labeling

HRA didn't have time to incorporate into its switch NDA instructions stated in proposed ACNU rule published in June, but the firm, which worked with Ibis Reproductive Health on proposal, had time to plumb a draft guidance FDA published in 2018 on novel switches.